Circ_0020123 promotes non‐small cell lung cancer progression via miR‐146a‐5p mediated regulation of EIF4G2 expression

Author:

Wei Zichun1,Liu Jixian1,Hui Gang1,Luan Xinyu1ORCID

Affiliation:

1. Department of Thoracic Surgery Peking University Shenzhen Hospital Shenzhen China

Abstract

AbstractBackgroundCircular RNAs (circRNAs) have been reported to be involved in the initiation and development of cancers. The aim of this study was to determine the role of a circRNA, circ_0020123, in the development of non‐small cell lung cancer (NSCLC).MethodsThe expression of circ_0020123, microRNA‐146a‐5p (miR‐146a‐5p), and eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) mRNA was detected by quantitative real‐time PCR (qPCR). Western blot was used to determine the protein levels of cyclin D1, Bax, MMP‐9, and EIF4G2. Cell proliferation was assessed by cell counting kit‐8 (CCK‐8) assay and colony formation assay. Flow cytometry assay was applied to determine cell cycle apoptosis. Cell migration and invasion were assessed using transwell assay. The potential relationship between miR‐146a‐5p and circ_0020123 or EIF4G2 was ascertained by dual‐luciferase reporter assay and RIP assay. The role of circ_0020123 in vivo was explored by xenograft assay.ResultsCirc_0020123 was upregulated in NSCLC, and circ_0020123 knockdown repressed proliferation, migration, and invasion of NSCLC cells. Circ_0020123 targeted miR‐146a‐5p, and miR‐146a‐5p inhibitor reversed the effects of circ_0020123 knockdown on NSCLC cells. In addition, miR‐146a‐5p suppressed cell proliferation, migration, and invasion by targeting EIF4G2. Moreover, the antitumor role of circ_0020123 knockdown was verified in vivo.ConclusionKnockdown of circ_0020123 inhibited NSCLC cell progression and tumor growth by targeting the miR‐146a‐5p/EIF4G2 axis.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3